The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The ARETHA study: A phase 2 randomized control trial of eribulin with evexomostat (SDX-7320) or placebo for patients with metastatic triple-negative breast cancer (TNBC) and metabolic dysfunction.
 
Sherry Shen
Honoraria - MJH Life Sciences
 
Verna Solomon
No Relationships to Disclose
 
Dominiq Williams
No Relationships to Disclose
 
Mark E. Robson
Consulting or Advisory Role - Change HealthCare
Research Funding - AstraZeneca (Inst); Merck (Inst); Pfizer (Inst); Zenith Pharmaceuticals (Inst)
Other Relationship - AstraZeneca; Clinical Care Options; Clinical Education Alliance; MJH Healthcare Holdings, LLC; MyMedEd; Pfizer; Physicans' Education Resource; Research to Practice
(OPTIONAL) Uncompensated Relationships - Artios; Daiichi Sankyo; Epic Sciences; Merck; Pfizer; Tempus; Zenith Pharmaceuticals
 
Larry Norton
Stock and Other Ownership Interests - Codagenix; Immix Biopharma; Martell Diagnostic; Medaptive Health; Samus
Honoraria - Bristol-Myers Squibb/Celgene; Codagenix; Cold Spring Harbor Laboratory; MSK Pharma; TGH Cancer Institute
Consulting or Advisory Role - Agenus; Bristol-Myers Squibb/Celgene; Codagenix; QLS Advisors
Expert Testimony - Humana v. Celgene
 
Tiffany A. Traina
Consulting or Advisory Role - Agendia; AstraZeneca; bioTheranostics; Blueprint Medicines; Daiichi Sankyo; Ellipses Pharma; Fuji Pharma; G1 Therapeutics; GE Healthcare; Genentech/Roche; Gilead Sciences; GlaxoSmithKline; Hengrui Pharmaceutical; Infinity Pharmaceuticals; ITeos Therapeutics; Merck; Novartis; Pfizer; SeaGen; Tersera
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Ayala Pharmaceuticals (Inst); Carrick Pharm (Inst); Daiichi Sankyo (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Innocrin Pharma (Inst); Novartis (Inst); Pfizer (Inst)
 
Neil M. Iyengar
Honoraria - Curio Science; IQvia; MJH Life Sciences; Total Health Conferencing
Consulting or Advisory Role - Novartis; Pfizer; Seagen; Tersera
Research Funding - American Cancer Society (Inst); Breast Cancer Research Foundation (Inst); Conquer Cancer Foundation (Inst); National Cancer Institute (Inst); Novartis (Inst); SynDevRx (Inst)